ArticleOncotarget2016

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.

Claudia C Roskopf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.